Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - LONG-TERM INVESTMENTS
Long-term Investments FATE - Fate Therapeutics, Inc.
980 K
LAST VALUE
-90.13%
2 YEAR CAGR
-14.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR